Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
D Goletti, L Petrone, G Ippolito, L Niccoli… - Expert Review of Anti …, 2018 - Taylor & Francis
Introduction: Latent tuberculosis infection (LTBI) accounts for almost a quarter of the world
population, and, in 5–10% of the subjects with impaired immune-response against M …
population, and, in 5–10% of the subjects with impaired immune-response against M …
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
D Goletti, L Petrone, G Ippolito… - Expert review of …, 2018 - pubmed.ncbi.nlm.nih.gov
Latent tuberculosis infection (LTBI) accounts for almost a quarter of the world population,
and, in 5-10% of the subjects with impaired immune-response against M. tuberculosis …
and, in 5-10% of the subjects with impaired immune-response against M. tuberculosis …
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs.
D Goletti, L Petrone, G Ippolito, L Niccoli… - Expert Review of Anti …, 2018 - europepmc.org
INTRODUCTION: Latent tuberculosis infection (LTBI) accounts for almost a quarter of the
world population, and, in 5-10% of the subjects with impaired immune-response against M …
world population, and, in 5-10% of the subjects with impaired immune-response against M …
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs.
D Goletti, L Petrone, G Ippolito, L Niccoli, C Nannini… - 2018 - cabidigitallibrary.org
Introduction: Latent tuberculosis infection (LTBI) accounts for almost a quarter of the world
population, and, in 5-10% of the subjects with impaired immune-response against M …
population, and, in 5-10% of the subjects with impaired immune-response against M …